Clinical use of macitentan in the treatment of connective tissue disease-associated pulmonary arterial hypertension

CONCLUSIONS: Exercise tolerance and cardiac function in patients with CTD-PAH were significantly improved after treatment with macitentan, which was well tolerated. Therefore, macitentan may be an effective and safe targeted drug for CTD-PAH.PMID:38617769 | PMC:PMC11009607 | DOI:10.21037/jtd-24-151

Source: Journal of Thoracic Disease - April 15, 2024 Category: Respiratory Medicine Authors: Xiaohui Song Xiangrui Sheng Lei Ding Jian Wu Xin Chang Erye Zhou Jing Cao Tao Cheng Mingjun Wang Source Type: research